Weei/nesn Jimmy Fund Radio-telethon

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 73:53:26
  • More information

Informações:

Synopsis

Interviews from the annual WEEI/NESN Jimmy Fund Radio-Telethon.

Episodes

  • Shelby Young, 49, breast cancer, Orrington ME, with Kristina Worcester, RN, Breast Oncology Nurse Navigator

    30/08/2023 Duration: 08min

    Shelby Young, 49, breast cancer, Orrington ME, with Kristina Worcester, RN, Breast Oncology Nurse Navigator Shelby has been having mammograms every 6 months for the past 2 years because ofdense breast tissue. In March 2022, the mammogram looked suspicious, so she had anultrasound later that day. A biopsy two weeks later confirmed that she had triple negative rightbreast cancer. She started treatment at Dana-Farber, once a week for 8 weeks, then once every3 weeks until April of 2023. Throughout that process, Shelby had a lumpectomy in September of2022 and a month of radiation in December.· Before the lumpectomy, Shelby’s surgeon placed a bead where the tumor had been, andafter removing the tissue around the bead area, the area came back negative for breast cancer.She is no longer in treatment. Shelby has had immense support from family and friends; as theTeam Mom for her daughter’s travel softball team, the support from all the girls has given herso much encouragement.· She works as a Registered Nurse in the E

  • Prostate Cancer Survivor & MLB Umpire Phil Cuzzi joins Joe Castiglione & Will Fleming

    30/08/2023 Duration: 19min

    Joe Castiglione and Will Fleming were joined by MLB Umpire Phil Cuzzi to discuss his journey to becoming an umpire, the pitch clock, being diagnosed with prostate cancer and quickly returning to baseball.

  • Jon Goff joins Joe & Will from the booth!

    30/08/2023 Duration: 06min

    Jon Goff, Sales Operation Manager for Volkswagen joins the guys from the booth to discuss his company's work with the Jimmy Fund. 

  • Jason Hayes joins Joe & Will from the booth!

    30/08/2023 Duration: 06min

    Jason Hayes, District Manager of the Sherwin Williams Company, announces the company is donating $10,000 to this year's Jimmy Fund Radio Telethon live from the WEEI Sox booth!

  • Sarah Shields joins Joe & Will from the booth!

    30/08/2023 Duration: 02min

    Sarah Shields, Marketing Manager of the Prudential Center, joins Joe and Will to explain what you can expect to find at the Pru live from the WEEI Sox booth!

  • Elle Simone Scott joins Joe & Will from the booth!

    30/08/2023 Duration: 05min

    As a cast member/chef on the television series “America’s Test Kitchen,” and host of its companion podcast “The Walk-In,” Elle Simone Scott delights in sharing her expertise and recipes. The Boston-based celebrity chef and food stylist is also a role model, as founder and president of SheChef, Inc., a professional networking organization for fellow women chefs of color seeking success in the food and beverage, media, and hospitality industries. Elle found a new doctor once she arrived in Boston, got another ultrasound, and learned she had a cyst with cancerous concerns on her right ovary. Her doctor referred her to Dr. Michael Muto at Dana-Farber Brigham Cancer Center and was diagnosed with stage I ovarian cancer. She had surgery to remove the right ovary and fallopian tubes, alongside chemotherapy. Elle went into remission for about 5 years until it came back in 2020 as recurrent ovarian cancer in her bowel and lower bladder. She went through more surgery and chemotherapy, and is now on an immunotherapy clin

  • Dodgers' Manager Dave Roberts discusses his battle with cancer with Joe Castiglione

    30/08/2023 Duration: 02min

    Dodgers' Manager Dave Roberts discusses his battle with cancer with Joe Castiglione.

  • Astros' Manager Dusty Baker sits down with Joe Castiglione to discuss his battle with cancer

    30/08/2023 Duration: 05min

    Astros' Manager Dusty Baker sits down with Joe Castiglione to discuss his battle with cancer.

  • An emotional Alex Cora joins Joe Castiglione to discuss the importance of the Jimmy Fund

    30/08/2023 Duration: 01min

    An emotional Alex Cora joins Joe Castiglione to discuss the importance of the Jimmy Fund

  • Arbella Insurance CEO John Donohue

    29/08/2023 Duration: 06min

    John F. Donohue is Chief Executive Officer of the Arbella Insurance Group andChairman of the Arbella Insurance Foundation. He is one of the founders of Arbella and has been Chairman of the Board of Directors since the company’s creation in 1988 and chairs the boards of each of the subsidiary companies. He is responsible for the strategic planning and corporate policy for all of the companies of the Arbella Insurance Group – a leader in the New England property/casualty insurance industry - as well as the strategic planning and giving initiatives for the Arbella Insurance Foundation. Since its inception in 2005, the Foundation has donated more than $40 million to charities across New England. The Arbella Insurance Group is proud to be the presenting sponsor of the WEEI/NESN Jimmy Fund Radio-Telethon again. This year marks the 15th year that Arbella has been the Presenting sponsor of the radio telethon. We are proud to support all the work Dana-Farber does to fight Cancer.

  • Hall of Famer David Ortiz will always be honest about the Red Sox

    29/08/2023 Duration: 12min

    Red Sox legend and Hall of Famer David Ortiz talks about the impact being part of the Jimmy Fund has meant to him, being a mentor to any current Red Sox players, and the recent return of Mookie Betts.

  • Celtics' Owner Steve Pagluica is ready for a future with Jayson Tatum and Jaylen Brown

    29/08/2023 Duration: 07min

    Part-owner of the Celtics Steve Pagluica joins via the Harbor One Hotline to talk about the Shamrock Foundation's contributions to the Jimmy Fund and the looming extension for Jayson Tatum on top of Jaylen Brown's.

  • Bryan Cruz, 14, acute lymphoblastic leukemia, Lynn, with Marta (mom), Jose (dad), Catelyn (sister, 11) and Catherine Glennon, Program Coordinator, Patient and Family Resources, Dana-Farber

    29/08/2023 Duration: 06min

    Bryan was diagnosed with acute lymphoblastic leukemia (ALL) in April 2022. He wascomplaining about back pain and his skin was pale. He also suffered from chronic nose bleeds. His parents took him to the emergency room when he was having bad pain. Blood work and x-rays came back clean, but he was sent to Children's Hospital for further evaluation. MRI and further blood work revealed that he had leukemia. His treatment includes chemotherapy and he is slated to be done with active treatment inMay 2024. ALL is the most common type of childhood cancer. It most often occurs in children ages 3 to 5 and affects slightly more boys than girls. About 3,000 people younger than age 20 are found to have ALL each year in the United States. Catherine is the program coordinator of patient and family resources at Dana-Farber's Jimmy Fund Clinic.

  • Yesenia Joseph, 36, breast cancer, Boston, with Harold 'Hal' Burstein, MD, PhD, Institute Physician, Breast Oncology, Dana-Farber

    29/08/2023 Duration: 06min

    After feeling a lump in her breast, Yesenia made an appointment to get checked by her primary care physician. She was diagnosed with triple negative breast cancer (TNBC) in January of this year. This type of breast cancer accounts for 10-15% of all breast cancer diagnoses and can be somewhat more difficult to treat. Her treatment plan has consisted of 5 months of chemotherapy starting in February, and more recently, a double mastectomy in early August. In October, she is scheduled to receive radiation treatment as well. Before coming to Dana-Farber, she met with a different doctor who gave her Dana-Farber doctor, Dr. Burstein, a great review. Yesenia checked Dr. Burstien’s reviews in the breast cancer community via Facebook groups and found that other patients thought very highly of him. She’s been pleased to be his patient and and finds it convenient to go to both the Longwood and Chestnut Hill locations. Neuroblastoma is a cancer often found in the small glands on top of the kidneys (adrenal glands), but ne

  • Larry Lucchino, Chairman of the Jimmy Fund, Trustee of Dana-Farber Cancer Institute, Chairman/Principal Owner of the Worcester Red Sox, and President/CEO Emeritus of the Boston Red Sox with Melany Duval, senior vice president, chief development officer, D

    29/08/2023 Duration: 07min

    Larry Lucchino is Chairman/Principal Owner of the Worcester Red Sox and Boston Red Sox President/CEO Emeritus, and Chairman of the Jimmy Fund. Just before his 40th birthday, Larry was diagnosed with non-Hodgkin lymphoma. Dana-Farber has helped save his life 3 times; first from non-Hodgkin lymphoma in 1985, second from prostate cancer in 2000, and third from cancer in the kidney area starting in 2019. Melany N. Duval has served as Senior VP and Chief Philanthropy Officer at Dana-Farber Cancer Institute and the Jimmy Fund since 2019. In that period of time, Dana-Farber has embarked on its most ambitious, multi-year fundraising effort to change the future of cancer research and care – the largest in its history and the largest ever focused solely on cancer. The Dana-Farber Campaign, aims to raise upwards of $2B for the Institute’s priorities: Revolutionary Science, Extraordinary Care, Exceptional Expertise and Essential Opportunities.

  • Austin Martin, 46, prostate cancer, Needham, with Alicia Morgans, MD, MPH, Medical Director, Survivorship Program, Dana-Farber

    29/08/2023 Duration: 06min

    When Austin switched to a new primary care doctor, his wife, Lindsay, told him to ask for everything at his first appointment, including a PSA levels check. Even though nurse practitioners don’t typically check for this at age 45, Austin requested and got it done anyway. That night, the doctor’s office called back and informed him that his PSA was off the charts. They originally thought it was high because he exercised, but after rerunning it, the results were the same. A biopsy confirmed that Austin had a rare type of prostate cancer called small-cell prostate cancer and he began to see Dr. Alicia Morgans at Dana-Farber for treatment. Small-cell prostate cancer is considered a mixed tumor, meaning surgery would not be an effective option for him. It’s like having 2 different types of cancer inside the same tumor. The small cell portion was confined to the prostate, but the other portion was starting to spread. Alicia Morgans is a Genitourinary Medical Oncologist and the Medical Director of the Survivorship P

  • Keith Johnson, 68, stomach cancer, Brookline, with Ben Schlechter, MD, Senior Physician, Gastrointestinal Cancer, Dana-Farber

    29/08/2023 Duration: 06min

    After initially experiencing mild symptoms such as intolerance for spicy and acidic foods and abdomen soreness, Keith Johnson, a neurologist at Mass General Brigham, went to see his primary care physician when he noticed that these symptoms had worsened after a few months. He was diagnosed with stomach adenocarcinoma or stomach cancer in March 2021 and was started on a combination of chemotherapy and immunotherapy at Dana-Farber Cancer Institute under the care of his oncologist Dr. Ben Schlechter. Most cancers of the stomach (about 90% to 95%) are adenocarcinomas. These cancers develop from the gland cells in the innermost lining of the stomach (the mucosa). The American Cancer Society’s estimates for stomach cancer in the United States for 2023 are about 26,500 new cases of stomach cancer and about 11,130 deaths. Stomach cancer accounts for about 1.5% of all new cancers diagnosed in the US each year and the average age of people when they are diagnosed is 68, as the cancer mostly affects older people. Dr. Sc

  • Karen Cummings, former Communications Specialist for Dana-Farber

    29/08/2023 Duration: 09min

    Karen Cummings, who is retired and living in Maine, worked in Communications atDana-Farber Cancer Institute from late 1995 to early 2007. She was mainly in charge of publicity for fundraising events, mostly for the Jimmy Fund,but also for special Dana-Farber events. She knew she was in for some exciting times when her very first event to publicize was a black-tie affair with Ted Williams when he returned to Boston for the opening of the Ted Williams Tunnel. The 50th anniversary of Dana-Farber was one year before that of the Jimmy Fund, so to get up to speed, Karen spent a lot of time going through files and reading old clippings about the founding of both. This work gave her extensive background to the early times of the Jimmy Fund and a giant clue that the original Jimmy might still be alive. Karen brought the original “Jimmy” back to Dana-Farber. Karen’s son is now a patient at Dana-Farber.

  • Red Sox pitcher Chris Sale is happy to turn a corner from the team's 13-5 loss

    29/08/2023 Duration: 13min

    Chris Sale and the Red Sox are coming off a bad-looking loss against the Astros, but Sale is thrilled to have a new day come and once again be a part of the Jimmy Fund.

  • Mary Worthington Kachadurian, 65, follicular lymphoma, Boston, with Ann S. LaCasce, MD, MMSc, Director, Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology

    29/08/2023 Duration: 08min

    Blood in her urine lead Mary to get a kidney stone scan, but incidentally revealed that she had lymphoma. She immediately called Dana-Farber and was connected with the Cancer Diagnostic Service at Dana-Farber Brigham Cancer Center, which was new at the time of her lymphoma finding in 2018. The staff there cared for and led her through an expedited process to an official diagnosis of follicular lymphoma. At the same time, Mary had been training for the 2018 Pan Mass Challenge. She started chemotherapy in the in the fall of 2018, every 3 weeks for 6 cycles, because the cancer had become more aggressive. Six weeks after the last treatment, Mary rode the 2-day Pan Mass Challenge to Provincetown and went into remission. After 3 years in remission, the cancer relapsed, and she is back in treatment as of June 2022. Now, she’s on a clinical trial and is awaiting FDA approval for the 3rd line treatment of her specific lymphoma. She feels honored to be on the trial, for herself, but also for all of the future patients

page 6 from 25